Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy".
Journal
Sarcoma
ISSN: 1357-714X
Titre abrégé: Sarcoma
Pays: Egypt
ID NLM: 9709257
Informations de publication
Date de publication:
Historique:
received:
10
07
2019
accepted:
15
07
2019
entrez:
20
9
2019
pubmed:
20
9
2019
medline:
20
9
2019
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1155/2018/2068517.].
Identifiants
pubmed: 31534435
doi: 10.1155/2019/7608743
pmc: PMC6732588
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
7608743Commentaires et corrections
Type : ErratumFor
Références
Sarcoma. 2018 Oct 24;2018:2068517
pubmed: 30473623